LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 46 filers reported holding LARIMAR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,918,360 | +26.2% | 16,941,357 | 0.0% | 1.47% | +30.2% |
| Q2 2023 | $53,026,447 | -30.9% | 16,941,357 | 0.0% | 1.13% | -33.8% |
| Q1 2023 | $76,744,347 | +9.7% | 16,941,357 | 0.0% | 1.71% | +18.2% |
| Q4 2022 | $69,967,804 | +29.1% | 16,941,357 | 0.0% | 1.45% | +34.2% |
| Q3 2022 | $54,212,000 | +374.4% | 16,941,357 | +190.6% | 1.08% | +357.2% |
| Q2 2022 | $11,427,000 | -51.6% | 5,830,249 | 0.0% | 0.24% | -55.3% |
| Q1 2022 | $23,613,000 | -62.5% | 5,830,249 | 0.0% | 0.53% | -60.0% |
| Q4 2021 | $62,908,000 | -6.4% | 5,830,249 | 0.0% | 1.32% | +0.5% |
| Q3 2021 | $67,223,000 | +17.4% | 5,830,249 | 0.0% | 1.31% | +29.0% |
| Q2 2021 | $57,253,000 | -23.8% | 5,830,249 | +13.3% | 1.02% | -35.6% |
| Q1 2021 | $75,162,000 | -31.8% | 5,144,539 | 0.0% | 1.58% | -27.4% |
| Q4 2020 | $110,145,000 | +41.1% | 5,144,539 | 0.0% | 2.18% | +14.6% |
| Q3 2020 | $78,043,000 | +18.1% | 5,144,539 | 0.0% | 1.90% | -1.3% |
| Q2 2020 | $66,107,000 | – | 5,144,539 | – | 1.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,746,265 | $12,440,580 | 3.30% |
| Opaleye Management Inc. | 1,401,000 | $6,346,530 | 1.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $76,744,347 | 1.71% |
| GREAT POINT PARTNERS LLC | 900,000 | $4,077,000 | 0.80% |
| DAFNA Capital Management LLC | 236,873 | $1,073,035 | 0.32% |
| Perceptive Advisors | 2,280,709 | $10,331,612 | 0.30% |
| Atlas Venture Advisors, Inc. | 292,184 | $1,323,594 | 0.28% |
| MANGROVE PARTNERS IM, LLC | 805,815 | $3,650,342 | 0.24% |
| Verition Fund Management LLC | 1,938,822 | $8,782,864 | 0.12% |
| Woodline Partners LP | 1,681,913 | $7,619,066 | 0.10% |